BURZYKOWSKI, Tomasz

Email Alert RSS Feed

Profile

Full Name
BURZYKOWSKI, Tomasz
Email
tomasz.burzykowski@uhasselt.be
 
Loading... 5 0 5 0 false
Loading... 6 0 5 0 false

Publications

Refined By:
Date Issued:  [2020 TO 2022]
Date Issued:  2022

Results 1-7 of 7 (Search time: 0.002 seconds).

Issue DateTitleContributor(s)TypeCat.
12022Relationship Among the Foraminal Area and Demographic and Clinical Characteristics of Patients with Low Back PainLorenc , Tomasz; BURZYKOWSKI, TomaszJournal ContributionA1
22022Clinical Trial Endpoints in Metastatic Cancer: Using Individual Participant Data to Inform Future Trials MethodologyGoldberg, Richard M.; Adams, Richard; BUYSE, Marc; Eng, Cathy; Grothey, Axel; Andre, Thierry; Sobrero, Alberto F.; Lichtman, Stuart M.; Benson, Al B.; Punt, Cornelis J. A.; Maughan, Tim; BURZYKOWSKI, Tomasz; Sommeijer, Dirkje; Saad, Everardo D.; Shi, Qian; Coart, Elisabeth; Chibaudel, Benoist; Koopman, Miriam; Schmoll, Hans-Joachim; Yoshino, Takayuki; Taieb, Julien; Tebbutt, Niall C.; Zalcberg, John; Tabernero, Josep; Van Cutsem , Eric; Matheson, Alastair; de Gramont, AimeryJournal ContributionA1
32022Surrogacy Beyond Prognosis: The Importance of “Trial-Level” SurrogacyBUYSE, Marc; Saad, Everardo D.; BURZYKOWSKI, Tomasz; Regan, Meredith M.; Sweeney, Christopher S.Journal ContributionA1
42022The case against censoring of progression-free survival in cancer clinical trials - A pandemic shutdown as an illustrationJamoul, Corinne; Collette, Laurence; Coart, Elisabeth; D'Hollander, Koenraad; BURZYKOWSKI, Tomasz; Saad, Everardo D; BUYSE, MarcJournal ContributionA1
52022Operational characteristics of generalized pairwise comparisons for hierarchically ordered endpointsDELTUVAITE-THOMAS, Vaiva; BURZYKOWSKI, TomaszJournal ContributionA1
62022Using an interim analysis based exclusively on an early outcome in a randomized clinical trial with a long-term clinical endpointBarrado, Leandro Garcia; BURZYKOWSKI, Tomasz; LEGRAND, Catherine; BUYSE, MarcJournal ContributionA1
72022Semi-parametric accelerated failure-time model: A useful alternative to the proportional-hazards model in cancer clinical trialsBURZYKOWSKI, TomaszJournal ContributionA1